Table 2 Clinical data of the 199 end-stage liver disease (Child-Pugh class A, child B, and child C)
From: Evaluation of seven gene signature for predicting HCV recurrence post-liver transplantation
| End-stage liver disease patients | ||||
|---|---|---|---|---|
| Child A | Child B | Child C | P value | |
| N=79 | N=43 | N=77 | ||
| Age |
60 a (55–64) |
55b (51–60) |
52c (48.50–57) | <0.001 HS |
| Hb.% |
12.5 a (11–13.70) |
12 b (10.70–13) |
12b (11–13) | 0.031 |
| WBCsX103 |
5.30 a (4.30–6.50) |
5.10 a (4–6) |
5.60 a (4–6.95) | 0.6 |
| PlateletsX103 |
130 b (96–160) |
156 ab (90–180) |
165 a (121–210) | <0.001 HS |
| ALT |
43 a (34–50) |
40 a (33–47) |
46 a (30–110) | 0.09 |
| AST |
52 a (45–63) |
48 a (29–65) |
46 a (21.5–86.5) | 0.509 |
| Alb. |
3.50 b (3.20–3.80) |
3.40 b (2.80–3.80) |
3.80 a (3.45–4.00) | <0.001 HS |
| Creat. |
1.00 a (0.90–1.10) |
1.00 a (0.90–1.10) |
1.00 a (0.90–1.10) | 0.86 |